Oscar Health (OSCR) director David Plouffe receives 1,257 deferred stock units

Rhea-AI Filing Summary

Oscar Health, Inc. director David Plouffe reported an award of deferred stock units as part of his board compensation. On January 8, 2026, he received 1,257 deferred stock units, each representing the right to receive one share of Oscar Health’s Class A common stock. The award was valued using the closing stock price of $16.90 per share on that date, which was used to calculate how many units he received in lieu of a cash retainer.

After this grant, Plouffe beneficially owns 5,393 deferred stock units, held directly. These units are fully vested on the grant date and will be settled, at the company’s discretion, in cash or Class A shares within 45 days after the earliest of his termination of service, a change in control, death, or disability.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Plouffe David

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Unit	1,257	$16.90	$21K

Holdings After Transaction: Deferred Stock Unit — 5,393 shares (Direct)

Footnotes (1)

1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on January 8, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Plouffe David

(Last) (First) (Middle)

75 VARICK STREET, 5TH FLOOR

(Street)

NEW YORK NY 10013

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Unit	(1)	01/08/2026		A		1,257		(3)	(3)	Class A Common Stock	1,257	$16.9(2)	5,393	D

Explanation of Responses:

1. Each deferred stock unit represents a right to receive one share of the Issuer's Class A common stock.

2. The Reporting Person elected, pursuant to the Issuer's Amended and Restated Deferred Compensation Plan for Directors, to receive deferred stock units in lieu of cash retainer payments for service on the Issuer's board of directors. The price of the deferred stock units reported herein represents the closing price of the Issuer's Class A common stock on January 8, 2026, which price was used to calculate the number of deferred stock units issued to the Reporting Person.

3. The deferred stock units will be settled for cash or shares of Class A common stock, in the Issuer's discretion, within 45 days of the first to occur of (i) termination of service; (ii) a change in control; (iii) death; or (iv) disability. Deferred stock units issued in lieu of a cash retainer payment are 100% vested on the grant date.

Remarks:

	/s/ Melissa Curtin, Attorney-in-fact	01/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Oscar Health (OSCR) report for David Plouffe?

Oscar Health reported that director David Plouffe received an award of 1,257 deferred stock units on January 8, 2026 as part of his board compensation.

How many Oscar Health (OSCR) deferred stock units does David Plouffe hold after this transaction?

Following the reported award, David Plouffe beneficially owns 5,393 deferred stock units of Oscar Health, held in direct ownership.

What does each deferred stock unit represent for Oscar Health (OSCR)?

Each deferred stock unit represents a right to receive one share of Oscar Health’s Class A common stock, to be delivered in cash or shares at the company’s discretion.

How was the number of deferred stock units for David Plouffe calculated at Oscar Health (OSCR)?

The number of units was based on the $16.90 closing price of Oscar Health’s Class A common stock on January 8, 2026, converting his cash retainer into 1,257 deferred stock units.

When will David Plouffe’s Oscar Health (OSCR) deferred stock units be settled?

The deferred stock units will be settled for cash or shares, at Oscar Health’s discretion, within 45 days after the earliest of termination of service, a change in control, death, or disability.

Are David Plouffe’s Oscar Health (OSCR) deferred stock units vested?

Yes. Deferred stock units issued in lieu of a cash retainer payment under Oscar Health’s director compensation plan are 100% vested on the grant date.